Advertisement
Singapore markets open in 6 hours 21 minutes
  • Straits Times Index

    3,289.42
    -23.93 (-0.72%)
     
  • S&P 500

    5,300.51
    +53.83 (+1.03%)
     
  • Dow

    39,830.66
    +272.55 (+0.69%)
     
  • Nasdaq

    16,726.59
    +215.41 (+1.30%)
     
  • Bitcoin USD

    65,378.06
    +4,122.85 (+6.73%)
     
  • CMC Crypto 200

    1,378.53
    +110.58 (+8.72%)
     
  • FTSE 100

    8,445.80
    +17.67 (+0.21%)
     
  • Gold

    2,393.10
    +33.20 (+1.41%)
     
  • Crude Oil

    78.63
    +0.61 (+0.78%)
     
  • 10-Yr Bond

    4.3560
    -0.0890 (-2.00%)
     
  • Nikkei

    38,385.73
    +29.67 (+0.08%)
     
  • Hang Seng

    19,073.71
    -41.35 (-0.22%)
     
  • FTSE Bursa Malaysia

    1,603.23
    -2.65 (-0.17%)
     
  • Jakarta Composite Index

    7,179.83
    +96.07 (+1.36%)
     
  • PSE Index

    6,558.63
    -49.73 (-0.75%)
     

Is There Now An Opportunity In LifePoint Health Inc (NASDAQ:LPNT)?

LifePoint Health Inc (NASDAQ:LPNT), a healthcare company based in United States, saw a decent share price growth in the teens level on the NasdaqGS over the last few months. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s examine LifePoint Health’s valuation and outlook in more detail to determine if there’s still a bargain opportunity. See our latest analysis for LifePoint Health

What’s the opportunity in LifePoint Health?

According to my valuation model, LifePoint Health seems to be fairly priced at around 7.68% below my intrinsic value, which means if you buy LifePoint Health today, you’d be paying a reasonable price for it. And if you believe the company’s true value is $58.76, then there isn’t much room for the share price grow beyond what it’s currently trading. Furthermore, LifePoint Health’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. This may mean it is less likely for the stock to fall lower from natural market volatility, which suggests less opportunities to buy moving forward.

Can we expect growth from LifePoint Health?

NasdaqGS:LPNT Future Profit June 21st 18
NasdaqGS:LPNT Future Profit June 21st 18

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. With profit expected to more than double over the next couple of years, the future seems bright for LifePoint Health. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? LPNT’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping tabs on LPNT, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on LifePoint Health. You can find everything you need to know about LifePoint Health in the latest infographic research report. If you are no longer interested in LifePoint Health, you can use our free platform to see my list of over 50 other stocks with a high growth potential.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.